A team of Lawrence Livermore National Laboratory (LLNL) researchers has discovered a promising new treatment to counteract ...

The fentanyl treatment discovered by LLNL scientists is subetadex, a compound first developed more than two decades ago in ...

A team of Lawrence Livermore National Laboratory (LLNL) researchers has discovered a promising new treatment to counteract ...

In patients with substantial renal impairment, compared with healthy subjects, the clearance of sugammadex and rocuronium was decreased by a factor of 17 and 4, respectively, and the elimination ...

Rocuronium, a non-depolarizing agent with a considerably longer half-life, is frequently used in these situations. This study was performed as a retrospective analysis of prospectively collected ...

It involves a three-drug cocktail, starting with the sedative Etomidate. This is followed by Rocuronium bromide, a paralytic agent. The final drug administered is Potassium acetate, used to stop ...

A global team of researchers at the Max Planck Institute of Biochemistry has made a groundbreaking discovery that saves the lives of patients suffering from toxic epidermal necrolysis.

Observations made on anesthetized patients with a recently introduced synthetic muscle relaxant, succinylcholine, indicated that this agent, administered in the form of continuous intravenous ...

Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti ...